In Vivo and in Vitro Uptake of 111In, Delivered With the Affibody Molecule (ZEGFR:955)2, in EGFR Expressing Tumour Cells

Oncology Reports - Greece
doi 10.3892/or.19.4.853
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Fluorescent Affibody Molecule Administered in Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions

Molecular Imaging and Biology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2016English

Targeted Delivery of 111In Into the Nuclei of EGFR Overexpressing Cells via Modular Nanotransporters With Anti-Egfr Affibody

Frontiers in Pharmacology
Pharmacology
2020English

Affibody‑mediated Imaging of EGFR Expression in Prostate Cancer Using Radiocobalt‑labeled DOTA‑ZEGFR:2377

Oncology Reports
MedicineCancer ResearchOncology
2018English

Antitumour 2-(4-Aminophenyl)benzothiazoles Generate DNA Adducts in Sensitive Tumour Cells in Vitro and in Vivo

British Journal of Cancer
Cancer ResearchOncology
2003English

Radiation Sensitivity of Tumour Cells Stained in Vitro or in Vivo With the Bisbenzimide Fluorochrome Hoechst 33342

British Journal of Cancer
Cancer ResearchOncology
1989English

Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule 111In-Dota-Zigf1r:4551

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2011English

111In-Danbirt in Vivo Molecular Imaging of Inflammatory Cells in Atherosclerosis

Contrast Media and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2018English

In Vivo Targeting of HER2-positive Tumor Using 2-Helix Affibody Molecules

Amino Acids
Organic ChemistryBiochemistryClinical Biochemistry
2011English

Qualitative and Quantitative Analysis of Tumour Invasion in Vivo and in Vitro

Journal of Cell Science
Cell Biology
1987English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy